A new twice-yearly antiviral injection that can prevent HIV is likely to be approved soon in Australia. Making it affordable ...

USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education and research in ...

UGANDA: UGANDA’S total number of people living with HIV has surpassed 1.5 million, according to the latest 2024 estimates ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

The approval of Yeztugo is a momentous step in improving PrEP options available for people vulnerable to contracting ...

Dr Reddy’s Laboratories prepares for US market challenges with strategic growth initiatives and strong financial performance in FY25.

Many fell under the President’s Emergency Plan for Aids Relief (Pepfar) programme, which has been the backbone of global ...

South Africa’s HIV programme is the biggest in the world, but now it’s been cut thin, with the loss of billions in US funding ...

The drug, in June, received FDA approval as the first twice-yearly pre-exposure prophylaxis (PrEP) option to reduce the risk ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...